妊娠期抗抑郁药使用模式:法国全国性队列研究
基于法国报销数据库2014年启动妊娠的766 508例妊娠队列,妊娠期抗抑郁药使用率为25.7/1000(95%CI 25.3-26.0),新使用为3.9/1000(95%CI 3.7-4.0)。多数治疗调整发生在孕前及孕早期,妊娠期停药后22%的妊娠恢复治疗。
要点
- 妊娠期抗抑郁药使用率25.7/1000,新使用率3.9/1000。
- 孕前63%的持续治疗在受孕前停用,孕早期68%的维持治疗停用。
- 换药最常转为舍曲林,联合治疗多为SSRI加三/四环类或米氮平/米安舍林。
核心结论
- 研究结果提示,大部分使用抗抑郁药的女性或妊娠后开始治疗的女性,其妊娠为计划妊娠或治疗根据现有推荐进行了特别调整。
研究设计与样本
- 基于法国报销医疗系统(覆盖约99%人口)数据的全国性基于人群的队列研究。
- 队列包括766 508例妊娠(755 519名女性),均为2014年启动妊娠者。
主要发现
- 妊娠期抗抑郁药使用率为25.7/1000(95%CI 25.3-26.0)。
- 妊娠期新使用抗抑郁药率为3.9/1000(95%CI 3.7-4.0)。
- 妊娠期最常起始的药物类别为选择性5-羟色胺再摄取抑制剂(SSRIs),而妊娠中晚期最常处方的单药为阿米替林(三环类)。
- 孕前一年持续治疗中63%在受孕前停用;受孕后维持的治疗中68%在孕早期停用。
- 换药或联合抗抑郁药多发生在围受孕期间或孕早期;无论初始抗抑郁药如何,换用舍曲林最常见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: We explored the patterns of antidepressant use during pregnancy. METHODS: A cohort of women who started a pregnancy in 2014 was identified using data from the French reimbursement healthcare system (covering approximately 99% of the population). Antidepressant usage (initiated before or during pregnancy) was assessed. Explored changes in antidepressant treatment were: associations, switches, discontinuation and resumption of antidepressants during pregnancy. RESULTS: The cohort included 766 508 pregnancies (755 519 women). Antidepressant use during pregnancy was 25.7 per 1000 [95% CI: 25.3-26.0]. New use concerned 3.9 per 1000 [95% CI: 3.7-4.0]; the most initiated class during pregnancy was selective serotonin reuptake inhibitors (SSRIs), while the most prescribed individual drug in second and third trimesters was amitriptyline, a tricyclic. Most changes were observed before pregnancy and during the first trimester: 63% of ongoing treatments in the year before pregnancy were discontinued before conception; 68% of treatments maintained after conception were discontinued during the first trimester; switches or antidepressant associations mostly occurred during the periconceptional period or during the first trimester. Regardless of initial antidepressant, switches to sertraline were the most frequent. Associations mainly consisted of a prescription of tri-/tetracyclic or mirtazapine/mianserin in addition to an SSRI. Discontinuation during pregnancy led to treatment resumption in 22% of pregnancies. CONCLUSIONS: These results suggest that pregnancy was planned or the treatment especially adapted in accordance with existing recommendations in a large proportion of women under antidepressants or in whom such treatments have been initiated after starting a pregnancy.
引用
- Bénard-Laribière A, Pambrun E, Sutter-Dallay AL, et al. Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study. Br J Clin Pharmacol. 2018. PMID: 29665098. doi:10.1111/bcp.13608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。